Life Sciences and Healthcare Regulatory


We have extensive experience with the various special statutory and regulatory frameworks applicable to products that contribute to biodefense and public health preparedness. In particular, we have advised an array of clients on strategies for seeking procurement decisions for national biosecurity stockpiles and associated policies and appropriations, and negotiated statutory and contractual protections for manufacturers of vaccines, antivirals, and other products to be used in response to a pandemic outbreak or bioterrorist attack. 

Our attorneys also work with colleagues in the firm's national security practice to assist clients in a broad range of industries as they work through the complex issues raised by the possibility of new and increased threats to personnel, facilities, and infrastructure, as well as the possible government need for critical goods and services during a time of emergency.


Update on transparency of clinical data
BioSlice Blog

Email Disclaimer